Ardalan Sayan, | |
705 N 8th Ave Ste 1b, Dillon, SC 29536-2549 | |
(843) 487-1588 | |
(843) 487-1590 |
Full Name | Ardalan Sayan |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 9 Years |
Location | 705 N 8th Ave Ste 1b, Dillon, South Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245626977 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Mcleod Home Health Inc | Florence, SC | Home health agency |
Kindred At Home | Florence, SC | Home health agency |
Carolinas Home Health | Florence, SC | Home health agency |
Mcleod Medical Center - Dillon | Dillon, SC | Hospital |
Mcleod Regional Medical Center-pee Dee | Florence, SC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mcleod Physician Associates Ii | 8224031307 | 520 |
News Archive
Meanwhile, implementation issues related to health exchanges, such as the importance of a state's insurance market, are emerging. Also, a model for exchange development has been unveiled.
More people than previously thought predicted a major change in U.S. health-care policy that led to a federal insider-trading probe, according to new documents assembled by congressional investigators.
A new rare muscle disorder has been identified by researchers at Ruhr-Universität Bochum. This hereditary disease is caused by a defect in the BICD2 gene that manifests itself in altered cellular transport processes in skeletal muscle cells.
According to the American Diabetes Association, there are 23.6 million children and adults living with diabetes in the U.S. Of this number, nearly 17.9 million people are currently undiagnosed, indicating that there is a dire need to increase awareness of the symptoms of the disease.
Janssen-Cilag International NV (Janssen) announced today that the Committee for Medical Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending approval of the oral, once-daily medication ZYTIGA for use in combination with prednisone or prednisolone in the treatment of metastatic castration-resistant prostate cancer (mCRPC), in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.
› Verified 8 days ago
Entity Name | Mcleod Physician Associates Ii |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801990494 PECOS PAC ID: 8224031307 Enrollment ID: O20060926000568 |
News Archive
Meanwhile, implementation issues related to health exchanges, such as the importance of a state's insurance market, are emerging. Also, a model for exchange development has been unveiled.
More people than previously thought predicted a major change in U.S. health-care policy that led to a federal insider-trading probe, according to new documents assembled by congressional investigators.
A new rare muscle disorder has been identified by researchers at Ruhr-Universität Bochum. This hereditary disease is caused by a defect in the BICD2 gene that manifests itself in altered cellular transport processes in skeletal muscle cells.
According to the American Diabetes Association, there are 23.6 million children and adults living with diabetes in the U.S. Of this number, nearly 17.9 million people are currently undiagnosed, indicating that there is a dire need to increase awareness of the symptoms of the disease.
Janssen-Cilag International NV (Janssen) announced today that the Committee for Medical Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending approval of the oral, once-daily medication ZYTIGA for use in combination with prednisone or prednisolone in the treatment of metastatic castration-resistant prostate cancer (mCRPC), in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Ardalan Sayan, 705 N 8th Ave Ste 1b, Dillon, SC 29536-2549 Ph: (843) 487-1588 | Ardalan Sayan, 705 N 8th Ave Ste 1b, Dillon, SC 29536-2549 Ph: (843) 487-1588 |
News Archive
Meanwhile, implementation issues related to health exchanges, such as the importance of a state's insurance market, are emerging. Also, a model for exchange development has been unveiled.
More people than previously thought predicted a major change in U.S. health-care policy that led to a federal insider-trading probe, according to new documents assembled by congressional investigators.
A new rare muscle disorder has been identified by researchers at Ruhr-Universität Bochum. This hereditary disease is caused by a defect in the BICD2 gene that manifests itself in altered cellular transport processes in skeletal muscle cells.
According to the American Diabetes Association, there are 23.6 million children and adults living with diabetes in the U.S. Of this number, nearly 17.9 million people are currently undiagnosed, indicating that there is a dire need to increase awareness of the symptoms of the disease.
Janssen-Cilag International NV (Janssen) announced today that the Committee for Medical Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending approval of the oral, once-daily medication ZYTIGA for use in combination with prednisone or prednisolone in the treatment of metastatic castration-resistant prostate cancer (mCRPC), in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.
› Verified 8 days ago
Michael J Sutton, DO Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 705 N 8th Ave, Suite 1b, Dillon, SC 29536 Phone: 843-487-1588 Fax: 843-487-1597 |